Literature DB >> 19034000

Endothelial cells in allograft rejection.

Rafia S Al-Lamki1, John R Bradley, Jordan S Pober.   

Abstract

In organ transplantation, blood borne cells and macromolecules (e.g., antibodies) of the host immune system are brought into direct contact with the endothelial cell lining of graft vessels. In this location, graft endothelial cells play several roles in allograft rejection, including the initiation of rejection responses by presentation of alloantigen to circulating T cells; the development of inflammation and thrombosis; and as targets of injury and agents of repair.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19034000      PMCID： PMC2658756          DOI： 10.1097/TP.0b013e3181891d8b

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  137 in total

Review 1.  Renal ischemia-reperfusion injury: new implications of dendritic cell-endothelial cell interactions.

Authors:  C L Schlichting; W D Schareck; M Weis
Journal:  Transplant Proc       Date:  2006-04       Impact factor: 1.066

2.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

Authors:  J S Pober; M A Gimbrone; L A Lapierre; D L Mendrick; W Fiers; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

3.  Antigen presentation by human microvascular endothelial cells triggers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent transendothelial migration of, effector memory CD4+ T cells.

Authors:  Thomas D Manes; Jordan S Pober
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

4.  Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.

Authors:  A D Luster; J C Unkeless; J V Ravetch
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

5.  Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.

Authors:  R N Salomon; C C Hughes; F J Schoen; D D Payne; J S Pober; P Libby
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

6.  TL1A both promotes and protects from renal inflammation and injury.

Authors:  Rafia S Al-Lamki; Jun Wang; Aviva M Tolkovsky; J Andrew Bradley; Jules L Griffin; Sathia Thiru; Eddie C Y Wang; Eleanor Bolton; Wang Min; Paul Moore; Jordan S Pober; John R Bradley
Journal:  J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 10.121

7.  Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential.

Authors:  Faouzia Zemani; Jean-Sébastien Silvestre; Françoise Fauvel-Lafeve; Arlette Bruel; José Vilar; Ivan Bieche; Ingrid Laurendeau; Isabelle Galy-Fauroux; Anne Marie Fischer; Catherine Boisson-Vidal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-31       Impact factor: 8.311

8.  Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.

Authors:  J S Pober; M P Bevilacqua; D L Mendrick; L A Lapierre; W Fiers; M A Gimbrone
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

9.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; W Fiers; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation.

Authors:  R de Jong; M Brouwer; F Miedema; R A van Lier
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422
View more
  44 in total

1.  CD31 signals confer immune privilege to the vascular endothelium.

Authors:  Kenneth Cheung; Liang Ma; Guosu Wang; David Coe; Riccardo Ferro; Marco Falasca; Christopher D Buckley; Claudio Mauro; Federica M Marelli-Berg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

2.  Cyclosporine Does Not Prevent Microvascular Loss in Transplantation but Can Synergize With a Neutrophil Elastase Inhibitor, Elafin, to Maintain Graft Perfusion During Acute Rejection.

Authors:  X Jiang; T T Nguyen; W Tian; Y K Sung; K Yuan; J Qian; J Rajadas; J-M Sallenave; N P Nickel; V de Jesus Perez; M Rabinovitch; M R Nicolls
Journal:  Am J Transplant       Date:  2015-02-27       Impact factor: 8.086

Review 3.  Transplantation immunology: solid organ and bone marrow.

Authors:  Javier Chinen; Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

4.  Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions.

Authors:  Cécile Taflin; Benoit Favier; Jeremy Baudhuin; Alain Savenay; Patrice Hemon; Armand Bensussan; Dominique Charron; Denis Glotz; Nuala Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

5.  Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.

Authors:  Laura Pisapia; Giovanna Del Pozzo; Pasquale Barba; Alessandra Citro; Paul E Harris; Antonella Maffei
Journal:  Results Immunol       Date:  2012-09-27

Review 6.  Translational implications of endothelial cell dysfunction in association with chronic allograft rejection.

Authors:  Sarah Bruneau; Johannes Wedel; Fadi Fakhouri; Hironao Nakayama; Leo Boneschansker; Daniel Irimia; Kevin P Daly; David M Briscoe
Journal:  Pediatr Nephrol       Date:  2015-04-24       Impact factor: 3.714

Review 7.  Cellular Based Strategies for Microvascular Engineering.

Authors:  Srinivas V Koduru; Ashley N Leberfinger; Denis Pasic; Anoosha Forghani; Shane Lince; Daniel J Hayes; Ibrahim T Ozbolat; Dino J Ravnic
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

8.  Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study.

Authors:  Yan Topilsky; Manish J Gandhi; Tal Hasin; Laurie L Voit; Eugenia Raichlin; Barry A Boilson; John A Schirger; Brooks S Edwards; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Sudhir S Kushwaha; Amir Lerman; Naveen L Pereira
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

Review 9.  Heart regeneration with engineered myocardial tissue.

Authors:  Kareen L K Coulombe; Vivek K Bajpai; Stelios T Andreadis; Charles E Murry
Journal:  Annu Rev Biomed Eng       Date:  2014-04-24       Impact factor: 9.590

10.  T cell extravasation: demonstration of synergy between activation of CXCR3 and the T cell receptor.

Authors:  Peter Newton; Graeme O'Boyle; Yvonne Jenkins; Simi Ali; John A Kirby
Journal:  Mol Immunol       Date:  2009-09-20       Impact factor: 4.407
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.